Time-course changes of contrast enhancement in iron colloid enhanced MRI in patients with hepatocellular Carcinoma

British Journal of Radiology

Volumn 69, Issue 819, 1996, Pages 201-205

  Suto, Y ^a   Ametani, M ^a   Kamba, M ^a   Sugihara, S ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BULTAL A; CHONDROITIN SULFATE IRON; CONTRAST MEDIUM; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; HUMAN; LIVER; LIVER CELL CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; SIGNAL NOISE RATIO; TIME;

EID: 0029976420     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/0007-1285-69-819-201     Document Type: Article

References (12)

1. NAKANISHI, Y, KURATA, K, YOSHIMURA, Y and OISE, S, Chondroitin sulphate iron colloid for intravenous injection (1st report): physico-chemical property and pharmacological significance (in Japanese), Yakugaku Zasshi, 86, 46-50 (1966).
2. 59Fe in organs (in Japanese), Yakugaku Zasshi, 90, 120-126 (1970).
3. SUTO, Y, KATO, T, MATSUO, T ET AL, Chondroitin sulphate iron colloid as MR contrast agent in differentiation between hepatocellular carcinoma and adenomatous hyperplasia, Acta Radiol., 34, 226-229 (1993)
4. KAMBA, M, SUTO, Y and KATO, T, Chondroitin sulphate iron colloid-enhanced MR imaging in patients with hepatocellular carcinoma: comparison with CT during arterial portography, Acta Radiol., 35, 570-575 (1994).
5. SUTO, Y and SHIMATANI, Y, Dual contrast magnetic resonance imaging with combined use of positive and negative contrast agent in human hepatocellular carcinoma, Br. J. Radiol., 68, 116-120 (1995).
6. SUTO, Y, KODAMA, F, KAMBA, M and OHTA, Y, Correlation between chondroitin sulphate iron colloid-enhanced MR imaging and the histological grade of hepatocellular carcinoma, Acta Radiol., 36, 102-105 (1995)
7. KADOYA, M, MATSUI, O, TAKASHIMA, T and NONOMURA, A, Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings, Radiology, 183, 819-825 (1992).
8. EDMONDSON, H A and STEINER, P E, Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies, Cancer, 7, 462-503 (1954).
9. KARIME S, Hypochrome anemia (in Japanese). In Handbook of Internal Medicine, Vol. 49, by F Takahisa, (Nakayama Publishing Inc., Tokyo), pp. 168-206 (1976).
10. SUGIHARA S, NAKASHIMA, O, KIYOMATSU, K ET AL, Pathomorphologic study on macrophage in hepatocellular carcinoma (in Japanese), Acta Hepatol. Jpn., 31, 12-18 (1990).
11. REIMER, P, KWONG, K K, WEISKOFF, R ET AL, Dynamic signal intensity changes in liver with superparamagnetic MR contrast agent, J. Magn Reson. Imaging, 2, 177-181 (1992)
12. TANIMOTO, A, YUASA, Y, IZUTSU, M ET AL, Time course of the liver contrast enhancement caused by superparamagnetic iron oxide (SPIO) (in Japanese), Nippon Jikikyoumei Kaishi, 13, 347 (1993).